PRF1 and neoplasm: Activated CTLs kill target tumor cells mainly through two pathways [39–41]: first, CTL release perforin (PFN) to transport secreted granzymes A and B (GzmA and GzmB) into tumor cells after forming pores in the tumor cell membrane, triggering an enzyme chain reaction that leads to apoptosis of tumor cells.